Upstate Active Clinical Trials

Study Title:

NRG-BR007: A Phase III Clinical Trial Evaluating De-escalation Of Breast Radiation For Conservative Treatment Of Stage I, Hormone Sensitive, Her2-Negative, Oncotype Recurrence Score < 18 Breast Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

To evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior
rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast
conservation with breast radiation and endocrine therapy.

Upstate Institutional Review Board (IRB) Number:

1838563

Study/Protocol ID:

NRG-BR007

Study Phase:

Phase III

Patient Age Group:

Adults

Principal Investigator:

Anna Shapiro, MD

What is involved if I participate?

• How long is the study?
  5 years.
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  Yes
• What tests and procedures are involved?
  Please contact the CRA for more information.

Where will the study take place?

Upstate Cancer Center - all procedures
The Hill Medical Center - all procedures
Oswego - all procedures
Verona - all procedures
Community Campus - Medical Oncology

Other Information:

Please contact the CRA for more information.

ClinicalTrials.Gov ID:

NCT04852887

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Erin Bingham, CCRP
Phone: 315-464-3603
Email: [email protected]

Return to Previous Page || Search Again